je.st
news
FDA Expands Approval Of Merck's Keytruda To Lung Cancer
2015-10-04 19:17:21| Biotech - Topix.net
The U.S. Food and Drug Administration on Friday approved Merck & Co Inc's immunotherapy, Keytruda, for patients with the most common form of lung cancer whose tumors produce a specific biological marker. The FDA approval for Keytruda in advanced non-small cell lung cancer is for patients whose tumors express PD-L1, a protein targeted by the drug, and includes a companion diagnostic, made by a unit of Agilent Technologies Inc, to measure those protein levels.
Tags: approval
cancer
lung
expands
Category:Biotechnology and Pharmaceuticals